Diabetic Retinopathy Market - Market Opportunity and Forecast by Technavio

Technavio has published a new market research report on the global diabetic retinopathy market 2018-2022 under their healthcare and life sciences library. (Graphic: Business Wire)

LONDON--()--Technavio has announced its newest market research report on the global diabetic retinopathy market for the period 2018-2022, providing the latest cutting-edge insights on this sought-after market.

The report will follow up on Technavio’s previous diabetic retinopathy research, providing an updated analysis of the market with regards to the current competitive landscape and global environment. The report will focus on meeting the requirements of the customer regarding the availability of statistics, analytics, data, and an accurate forecast of the diabetic retinopathy market. The research has been conducted keeping a base year as a reference to identify the retinopathy market trends and thereby accurately project the forecast of the market.

The updated research report on the global diabetic retinopathy market is an integral part of Technavio’s cardiovascular and metabolic disorders portfolio. Technavio covers an extensive range of market research reports on cardiovascular and metabolic disorders, analyzing different regions and top industry segments. Some of the topics covered include inflammatory bowel disease, rheumatoid arthritis, age-related muscular degeneration, and human growth hormone.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers

Diabetic retinopathy: market opportunities

Diabetic retinopathy is a disorder of the eye, which damages the blood vessels of the retina. Long-term diabetes affects the retina because high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is classified into non-proliferative diabetic retinopathy and proliferative retinopathy. The treatment for diabetic retinopathy depends on the stage of the disease and is usually directed toward slowing down or stopping the progression of the disease. Some of the treatments that are available include laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy.

In the previous report, a senior research analyst at Technavio stated, “One of the features of diabetic retinopathy is diabetic macular edema. It is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye that then collects in the macula. This results in inflammation of tissue and blurry vision. The increase in patient population has been a major factor that is promoting the growth of the market.”

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Topics covered in the previous report included the following:

Key sectors

  • Biologics
  • Corticosteroids

Key regions

  • APAC
  • EMEA
  • Americas

Other features

  • Market drivers
  • Market challenges
  • Market trends
  • Competitive landscape
  • And more

Using its previous analysis as a starting point, Technavio’s new report will re-evaluate the market with an eye for new developments in the field of diabetic retinopathy, as well as external factors and new competitors. The cardiovascular and metabolic disorders sector is extremely competitive and characterized by rapid ranges in the demand-supply landscape.

Big savings with Technavio this February!


Get 20% OFF on all Education Technology reports. This offer is valid only till the 28th of this month.




Celebrate winter sports with 23% OFF on all reports in the Outdoor Gear library (Offer valid from Feb 9-25).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

Technavio has announced its newest market research report on the global diabetic retinopathy market for the period 2018-2022.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200